Search Results - Rodrigo Dienstmann
- Showing 1 - 20 results of 30
- Go to Next Page
-
1
-
2
Reply to R. Freitas-Junior et al by Cristiano A.A. Resende, Rodrigo Dienstmann, Max S. Mano
Published in JCO Global Oncology (2023-06-01)Get full text
Article -
3
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies by Greta Catani, Greta Catani, Daniel Morchón-Araujo, Daniel Morchón-Araujo, Oriol Mirallas, Oriol Mirallas, Oriol Mirallas, Vicky Sánchez-Pérez, Vicky Sánchez-Pérez, Paolo Nuciforo, Paolo Nuciforo, Guillermo Villacampa, Rodrigo Dienstmann, Rodrigo Dienstmann, Rodrigo Dienstmann, Ana Vivancos, Elena Garralda, Elena Garralda, Alberto Hernando-Calvo, Alberto Hernando-Calvo
Published in Frontiers in Immunology (2025-10-01)Get full text
Article -
4
-
5
Outcome of Immunotherapy in Advanced Cervical Cancer after Progression to Platinum-Based Therapy in the Real World by Giovanna Vieira Giannecchini, Rafael Duarte Paes, Christopher Lucas Negrete, Rodrigo Dienstmann, Andreia Cristina de Melo
Published in Brazilian Journal of Oncology (2025-01-01)Get full text
Article -
6
Complete Response to Immunotherapy in a Patient with MUTYH-Associated Polyposis and Gastric Cancer: A Case Report by Maria Cecilia Mathias-Machado, Renata D. Peixoto, Patricia Ashton-Prolla, Leonard Medeiros da Silva, Rodrigo Dienstmann
Published in Case Reports in Oncology (2023-07-01)Get full text
Article -
7
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective by Bruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa e Silva, Rodrigo Dienstmann, Carlos Gil Ferreira, César Serrano
Published in JCO Global Oncology (2023-09-01)Get full text
Article -
8
-
9
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients by Tomás Reinert, Tomás Reinert, Fernanda Orpinelli do Rego, Matheus Costa e Silva, Amanda Muniz Rodrigues, Fernanda Christtanini Koyama, Aline Coelho Gonçalves, Maiane Maria Pauletto, Leandro Jonata de Carvalho Oliveira, Cristiano Augusto Andrade de Resende, Luciana Castro Garcia Landeiro, Carlos Henrique Barrios, Max Senna Mano, Rodrigo Dienstmann, Rodrigo Dienstmann
Published in Frontiers in Oncology (2024-06-01)Get full text
Article -
10
Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma by Daniel Herchenhorn, Rodrigo Dienstmann, Fabio A. Peixoto, Franz S. de Campos, Valdelice O. Santos, Denise M. Moreira, Hedilene Cardoso, Isabele A. Small, Carlos G. Ferreira
Published in International Brazilian Journal of Urology (2007-10-01)Get full text
Article -
11
The average cost of treatment according to lung cancer stage using real-world data by Pedro Aguiar Junior, Pedro De-Marchi, Rafael Paes, Isabella Favato, Gabriela Monte, Tatiane Montella, Filipe Visani, Nathalia Afonso, Izabella Negreiros, Rodrigo Dienstmann, Carlos Gil Ferreira
Published in Brazilian Journal of Oncology (2023-12-01)Get full text
Article -
12
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking? by Marta Ligero, Bente Gielen, Victor Navarro, Pablo Cresta Morgado, Olivia Prior, Rodrigo Dienstmann, Paolo Nuciforo, Stefano Trebeschi, Regina Beets-Tan, Evis Sala, Elena Garralda, Raquel Perez-Lopez
Published in npj Precision Oncology (2024-02-01)Get full text
Article -
13
Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario by Flavia A. Duarte, Carlos Gil Ferreira, Rodrigo Dienstmann, Bruno L. Ferrari, Matheus Costa E Silva, Pedro Nazareth A. Junior, Paulo Guilherme de O. Salles, Paulo Henrique C. Diniz
Published in Journal of Market Access & Health Policy (2022-12-01)Get full text
Article -
14
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer by Daan G. Knapen, Sara Hone Lopez, Derk Jan A. de Groot, Jacco-Juri de Haan, Elisabeth G. E. de Vries, Rodrigo Dienstmann, Steven de Jong, Arkajyoti Bhattacharya, Rudolf S. N. Fehrmann
Published in Communications Medicine (2024-05-01)Get full text
Article -
15
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations by David Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, Michael P. Schroeder, Ana Vivancos, Ana Rovira, Ignasi Tusquets, Joan Albanell, Jordi Rodon, Josep Tabernero, Carmen de Torres, Rodrigo Dienstmann, Abel Gonzalez-Perez, Nuria Lopez-Bigas
Published in Genome Medicine (2018-03-01)Get full text
Article -
16
Brazilian real-world data of immunotherapy in extensive stage small cell lung cancer by Flavia A. Duarte, Rodrigo Dienstmann, Paulo H. C. Diniz, Matheus C. e Silva, Gilson G. V. Veloso, Georgia S. Arcanjo, Rafael Paes, Tatiane C. Montella, Helena F. C. A. Lima, Bruno L. Ferrari, Eliane V. Macuzo, Carlos G. Ferreira
Published in Frontiers in Oncology (2025-02-01)Get full text
Article -
17
Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scoresResearch in context by Galip Can Uyar, Oriol Mirallas, Kadriye Başkurt, Berta Martin-Cullell, Enes Yeşilbaş, Jordi Recuero-Borau, Seher Kaya, Victor Navarro Garcés, Sevgi Eryıldız Yücel, Kreina Sharela Vega Cano, Diego Gómez-Puerto, Anna Pedrola Gómez, Clara Salva de Torres, Ömür Berna Çakmak Öksüzoğlu, Sonia Serradell, Rodrigo Dienstmann, Osman Sütcüoğlu
Published in The Lancet Regional Health. Europe (2025-07-01)Get full text
Article -
18
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers by Leticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, Daniel G. Tiezzi, Guillermo Villacampa, Samuel Gonçalves-Ribeiro, Laia Paré, Carla Anjos Souza, Vanesa Ortega, Stephen-John Sammut, Pol Cusco, Roberta Fasani, Suet-Feung Chin, Jose Perez-Garcia, Rodrigo Dienstmann, Paolo Nuciforo, Patricia Villagrasa, Isabel T. Rubio, Aleix Prat, Carlos Caldas
Published in npj Breast Cancer (2021-06-01)Get full text
Article -
19
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre net... by Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz‐Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Santos Vivas
Published in Molecular Oncology (2023-09-01)Get full text
Article -
20
Precision Oncology: A Global Perspective on Implementation and Policy Development by Denis Horgan, Marcel Tanner, Charu Aggarwal, David Thomas, Surbhi Grover, Lina Basel-Salmon, Rodrigo Dienstmann, Tira Jing Ying Tan, Woong-Yang Park, Hadi Mohamad Abu Rasheed, Lillian L. Siu, Brigette Ma, Rocío Ortiz-López, Marc Van den Bulcke, Silvia Castillo Taucher, Andrea Ferris, Naureen Starling, Umberto Malapelle, John Longshore, Hugo Alberto Barrera Saldaña, Vivek Subbiah
Published in JCO Global Oncology (2025-04-01)Get full text
Article
